A significant number of pregnancies are lost in the first trimester and 1–2% are ectopic
pregnancies (EPs). Early pregnancy loss in general can cause significant morbidity with …

The aim of this preliminary study was to investigate the potential of maternal serum to
provide metabolomic biomarker candidates for the prediction of spontaneous preterm birth …

Introduction Currently there are no clinical screening tests available to identify pregnancies
at risk of developing preeclampsia (PET) and/or intrauterine growth restriction (IUGR), both …

Prediction of spontaneous preterm birth (sPTB) in asymptomatic women remains a great
challenge; accurate and reproducible screening tools are still not available in clinical …

Early embryonic development arrest (EEDA) is a unique form of early spontaneous abortion
in pregnant women, which is previously suggested to be associated with metabolic …

Understanding of causal biology and predictive biomarkers are lacking for hypertensive
disorders of pregnancy (HDP) and preterm birth (PTB). First-trimester serum specimens from …

Introduction Ectopic pregnancy (EP) is a potentially life-threatening condition and early
diagnosis still remains a challenge, causing a delay in management leading to tubal rupture …

Objective Ectopic pregnancy (EP) is well known for its critical maternal outcome. Early
detection could make the difference between life and death in pregnancy. Our aim was to …

Introduction Maternal metabolism changes substantially during pregnancy. However, few
studies have used metabolomics technologies to characterize changes across gestation …

Background Differentiating between a normal intrauterine pregnancy (IUP) and abnormal
conditions including early pregnancy loss (EPL) or ectopic pregnancy (EP) is a major clinical …